 | Up a level |
Gold, Ralf; Barnett, Michael; Chan, Andrew; Feng, Huiyu; Fujihara, Kazuo; Giovannoni, Gavin; Montalbán, Xavier; Shi, Fu-Dong; Tintoré, Mar; Xue, Qun; Yang, Chunsheng; Zhou, Hongyu (2023). Clinical use of dimethyl fumarate in multiple sclerosis treatment: an update to include China, using a modified Delphi method. Therapeutic advances in neurological disorders, 16(17562864231180734), p. 17562864231180734. Sage 10.1177/17562864231180734
Bendfeldt, Kerstin; Taschler, Bernd; Gaetano, Laura; Madoerin, Philip; Kuster, Pascal; Mueller-Lenke, Nicole; Amann, Michael; Vrenken, Hugo; Wottschel, Viktor; Barkhof, Frederik; Borgwardt, Stefan; Klöppel, Stefan; Wicklein, Eva-Maria; Kappos, Ludwig; Edan, Gilles; Freedman, Mark S.; Montalbán, Xavier; Hartung, Hans-Peter; Pohl, Christoph; Sandbrink, Rupert; ... (2019). MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry. Brain imaging and behavior, 13(5), pp. 1361-1374. Springer 10.1007/s11682-018-9942-9
Fitzgerald, Kathryn C; Munger, Kassandra L; Hartung, Hans-Peter; Freedman, Mark S; Montalbán, Xavier; Edan, Gilles; Wicklein, Eva-Maria; Radue, Ernst-Wilhelm; Kappos, Ludwig; Pohl, Christoph; Ascherio, Alberto; BENEFIT, Study Group (2017). Sodium intake and multiple sclerosis activity and progression in BENEFIT. Annals of neurology, 82(1), pp. 20-29. Wiley-Blackwell 10.1002/ana.24965
Kappos, Ludwig; Edan, Gilles; Freedman, Mark S; Montalbán, Xavier; Hartung, Hans-Peter; Hemmer, Bernhard; Fox, Edward J; Barkhof, Frederik; Schippling, Sven; Schulze, Andrea; Pleimes, Dirk; Pohl, Christoph; Sandbrink, Rupert; Suarez, Gustavo; Wicklein, Eva-Maria; Mattle, Heinrich (2016). The 11-year long-term follow-up study from the randomized BENEFIT CIS trial. Neurology, 87(10), pp. 978-987. American Academy of Neurology 10.1212/WNL.0000000000003078
